Funding Opportunities

NIH Funding Opportunities

NHLBI Announces Plans to Fund a Jackson Heart Study Exam 4
Notice NOT-HL-17-542 from the NIH Guide for Grants and Contracts
Wed, 18 Oct 2017 01:52:53 EST

Notice of Upcoming Webinar for the Jackson Heart Study Renewal - Coordinating Center
Notice NOT-HL-17-552 from the NIH Guide for Grants and Contracts
Tue, 17 Oct 2017 08:42:49 EST

Notice of Upcoming Webinar for the Jackson Heart Study Renewal - Community Engagement Center
Notice NOT-HL-17-553 from the NIH Guide for Grants and Contracts
Tue, 17 Oct 2017 08:42:45 EST

Notice of Upcoming Webinar for the Jackson Heart Study Renewal - Training and Education Center
Notice NOT-HL-17-554 from the NIH Guide for Grants and Contracts
Tue, 17 Oct 2017 08:42:41 EST

Notice of Upcoming Webinar for the Jackson Heart Study Renewal - Field Center
Notice NOT-HL-17-555 from the NIH Guide for Grants and Contracts
Tue, 17 Oct 2017 08:51:50 EST

RFP Announcement: Jackson Heart Study Renewal - Field Center
Notice NOT-HL-17-556 from the NIH Guide for Grants and Contracts
Mon, 16 Oct 2017 08:52:01 EST

Technical Assistance Webinar for Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (PAR-17-483 and PAR-17-484 )
Notice NOT-MD-18-001 from the NIH Guide for Grants and Contracts
Wed, 18 Oct 2017 10:21:13 EST

Notice of Change to Award Budget Section for PAR-17-485 "NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25)"
Notice NOT-MH-18-002 from the NIH Guide for Grants and Contracts
Tue, 17 Oct 2017 01:38:47 EST

Research Centers for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (UM1)
Funding Opportunity RFA-CA-17-042 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative established to accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): the Implementation of Integrated and Evidenced-based Symptom Management Throughout the Cancer Trajectory. The purpose of this specific FOA is to promote research on the implementation and evaluation of integrated symptom monitoring and management systems for use in cancer care delivery through a Research Consortium. This research will provide new insights and valuable evidence that can be used to guide efforts on a nation-wide basis to improve symptom control for cancer patients during treatment and survivorship.
Wed, 18 Oct 2017 10:16:02 EST

Coordinating Center for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (U24)
Funding Opportunity RFA-CA-17-043 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative established to accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): the Implementation of Integrated and Evidenced-based Symptom Management Throughout the Cancer Trajectory. The purpose of this specific FOA is to promote research on the implementation and evaluation of comprehensive symptom management systems for use in cancer care delivery through a Research Consortium. This research will provide new insights and valuable evidence that can be used to guide efforts on a nation-wide basis to improve symptom control for cancer patients during treatment and survivorship.
Wed, 18 Oct 2017 10:15:59 EST

Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PATC3H) (UG3/UH3)
Funding Opportunity RFA-HD-18-032 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to stimulate much needed research in an important area of public health significance: prevention of new HIV infections among adolescents at risk, and the identification of, linkage to and retention in care of, and long term viral suppression among youth living with HIV in low-to-middle income countries. These settings must have an HIV epidemic density defined by UNAIDS estimates as either a country 1) in which at least 200,000 people are living with HIV and the number has not decreased by more than 5% over the last 2 consecutive years of available data or 2) has an HIV prevalence of 3% or more. The UG3/UH3 Phased Innovation Awards Cooperative Agreement involves 2 phases. Funding for a UG3 phase will be used to demonstrate sufficient preparation, feasibility and capacity to meet foundational milestone targets specific to the work proposed. A UG3 project that meets its milestones will be administratively considered by NICHD and prioritized for transition to the UH3 award. Applicants responding to this FOA must address objectives for both the UG3 and UH3 phases.
Wed, 18 Oct 2017 09:45:41 EST

Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
Funding Opportunity PAR-18-324 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to fund highly innovative and promising research that tests multi-level physical activity intervention programs acting on at least two levels of the socio-ecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity; and 2) that could be made scalable and sustainable for broad use across the nation. This FOA provides support for up to 5 years for research planning, intervention delivery, and follow-up activities.
Tue, 17 Oct 2017 11:42:04 EST